Healthcare Sector’s Stocks to Watch – ZIOPHARM Oncology Inc. (NASDAQ:ZIOP), MannKind Corporation (NASDAQ:MNKD).
Massapequa Park – April 1, 2013 — (Net PR News) -King Penny Stocks is an elite financial community for investors and traders alike who are looking to potentially gain financial freedom through the markets on undervalued companies and “in-play” momentum penny stocks. Today, we bring a special trend analysis of the following stocks: ZIOPHARM Oncology Inc., (NASDAQ:ZIOP)MannKind Corporation (NASDAQ:MNKD)
PLUS you’ll get KingPennyStock’s Pro Trading Rules Mini E-book absolutely FREE! Claim Your Copy
Trend analysis report of stocks at the Biotechnology industry of the Healthcare Sector. ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) remained a high volume stock in its industry and showing bullish momentum during previous trade and MannKind Corporation (NASDAQ:MNKD) showed bullish movement and in the news during the last trading session due to their latest news and sizzling activities.
ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) revealed its GAAP net loss remained $30.2 million, or $0.37 per share, for the 4th Q of 2012, in comparison to the last year same quarter of $13.2 million, or $0.19 per share.
How Should Investors Trade ZIOP Now? Don’t Miss out on a Special Trend Analysis
The GAAP net loss of ZIOP reported $96.1 million, or $1.22 per share, for the year 2012, versus the last year of $63.8 million, or $0.97 per share.
Healthcare Sector company moving up during previous trade, ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) ended its day with the gain of 6.40% and closed at the price of $1.83 after opening at $1.70. Stock traded during its last trading session with the total volume of 5.09 million shares, as compared to its average volume of 2.98 million shares.
During the previous session, the company’s minimum price was $1.68, while it touched its highest price for the day at $1.89. ZIOP’s beta value stands at 1.57 points. During the last one month, the company plunged -58.78%, while its last 5 days shows a drop of -64.4%.
What Are ZIOP’s Charts Signaling for Traders? Find Out Here
MannKind Corporation (NASDAQ:MNKD) reported its total operating expenses for the 4th quarter of 2012 remained $33.5 million, a $2.9 million rise, in comparison to the same period last year of $30.6 million.
The total operating expenses of MNKD for the year 2012 reported $147.0 million, $6.4 million up, versus the year ago of $140.6 million.
Should MNKD be a Buy or Sell Now? Find Out Here
MannKind Corporation was showing an upward trend during the previous trading session. MannKind Corporation (NASDAQ:MNKD) reported the increase of 0.59% to close at $3.39 with the overall traded volume of 3.89 million shares.
MannKind Corporation (NASDAQ:MNKD) has the total of 286.04 million outstanding shares. During last trade, the company’s minimum price was $3.33 while it touched its highest price of $3.41.
Its market capitalization was $969.66 million. Its beta value stands at 1.06 times and earnings per share was $-0.95. Company’s year to date performance remained optimistic with the climb of 46.75%. If we look at the last 6 months of trade, that is in the bullish zone with the rise of 17.71%.
King Penny Stocks provides up to the minute dissemination of news while reporting on stocks that are actively traded in the small cap arena whether trading on the Nasdaq small caps, AMEX or the OTC markets. Since performance is key in our industry, it’s no wonder why our ground breaking alerts on active stocks have brought us to the forefront of this industry. Our due diligence on trend analysis has caught the attention of the very best chart technicians in the business.
King Penny Stocks is an elite financial community for investors and traders alike who are looking to potentially gain financial freedom through the markets on undervalued companies and “in-play” momentum penny stocks. Get detailed breakdowns of major trends impacting the markets.
Our newsletter, Press Release and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company.
An individual should never invest in the securities of any of the companies profiled based solely on information contained in our report. Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research. This report/release/advertisement is a commercial advertisement and is for general information purposes only. We are engaged in the business of marketing and advertising companies for monetary compensation.
Read our Full Disclaimer at: http://kingpennystocks.com/disclaimer/